Only a minority of previous studies aimed at evaluating TIL in the entire margin of HCC and demonstrated the positive impact of CD3+ [17] and CD8+ cells on DFS [17,31], and CD20+ on TTR and OS [14]. This evidence concerns the gene CD8A and hepatocellular carcinoma.